kamada.com (KMDA) Quarterly EPS earnings growth

Symbol and logo of brand Kamada Pharma (KMDA)

The history of quarterly earnings per share changes confirms the pricing power of Kamada Ltd. (KMDA) due to the indispensability of the drug Glassia. High business margins are based on exclusive plasma protein purification methods. Meanwhile, the 51.20 indicator reflects the status of current yields. Growth prospects rely on the systematic development of the R&D pipeline and the introduction of new inhalation therapy forms.

KMDA: Kamada Year-over-year earnings per one share growth for the last 12 months 07/04/2022 - 11/14/2026

Kamada Pharma (KMDA) - metric breakdowns and financial figures

- share price and expert price forecast:
Stock Price Kamada|KMDA - Average Forecast Price
- market capitalization details:
Market Capitalization Kamada Corp|KMDA - Business Value
- balance sheet net asset value indicators:
Accounting Value per Share Kamada|KMDA - Accounting Value of Company|Market Value to Book Value Ratio kamada.com|KMDA - Total Asset Value of Company
- debt and solvency information:
Total Debt to Capital Kamada Ltd.|KMDA - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Kamada Ltd.|KMDA - Company Aggregate Debts|Debt to Book Capitalization Ratio Kamada Corp|KMDA - Company Long-Term Loans and Borrowings|Company Short-Term Debt Kamada|Quick Ratio kamada.com
- earnings and valuation multiples information:
KMDA - Net Profit|Expected Profit Kamada Ltd.|KMDA - P/E Multiple|Forward P/E Multiple Kamada Corp|KMDA - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Kamada Corp|KMDA - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) Kamada|KMDA - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth kamada.com|KMDA - Earnings per share growth this year|Earnings growth forecast for next year Kamada Ltd.
- sales revenue and business income indicators:
KMDA - Revenue and Sales Volume|Company Future Sales Volume Kamada|KMDA - Market Capitalization-to-Revenue Ratio|Price-to-Projected Revenue Ratio Kamada Corp
Initial company analysis:Kamada Ltd.
Flagship merchandise of Kamada Pharma

To diversify the portfolio with high-quality assets, I prioritize cash flow stability. This indicator measures the percentage deviation of current net earnings per share from the value of the same quarter last year. This trend confirms the operational resilience of Kamada Ltd. (KMDA) management during its expansion into the US market. By analyzing the quarterly change in earnings per share, an investor can identify the risk of a "value trap." The positive trend on this chart signals an increase in business margins.

Who Kamada Ltd. competes with

VRTX: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Alnylam Pharmaceuticals, Inc. (ALNY)|INSM (Insmed Inc) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months UTHR (United Therapeutics Inc.)|Year-over-year net earnings per share growth for the last 12 months BMRN (BioMarin Pharmaceutical)|BBIO (bridgebio.com) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months BGM Group BGM|COGT (Cogent Biosciences Inc) - Year-over-year net earnings per share trend for the last twelve months|Xeris Biopharma Inc - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months KROS (Keros Corp)|ARCT: Quarterly EPS earnings growth|etonpharma.com (ETON) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Fulcrum Therapeutics, Inc.|ABEO: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Mereo BioPharma (MREO)|Year-over-year net earnings per share growth for the last 12 months Protalix BioTherapeutics, Inc PLX|Quarterly EPS earnings growth PLRX (Pliant Therapeutics, Inc.)|Quarterly EPS earnings growth Applied Therapeutics Inc. APLT|RNTX - Year-over-year earnings per share growth for the last twelve months|GELS - Quarterly EPS earnings growth|AYTU: Quarterly EPS earnings growth|Chemomab Therapeutics Ltd. (CMMB) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months SRx Health Solutions Inc|Year-over-year net earnings per share growth for the last 12 months Polyrizon Ltd. (PLRZ)|Quarterly EPS earnings growth AEZS|Quarterly EPS earnings growth Cyclo Therapeutics Inc. (CYTH)|Quarterly EPS earnings growth INZY (Inozyme Pharma)|RPHM: Year-over-year earnings per share growth for the last 12 months|COSCIENS Biopharma Inc. - Quarterly EPS earnings growth